Country
United Kingdom
City
Cambridge
Headquarters
Cambridge, England
Founded
2008
Industry
Biotechnology Research
Size
51 - 200
Specialties
Organ-on-a-chip, Hepatitis B, drug discovery, liver disease, containment level 3 laboratory, microfluidic cell culture, precision biology, non-alcoholic steatohepatitis, Organ-on-Chip, Preclinical drug discovery, Microphysiological systems, Safety Toxicology, non-alcoholic fatty liver disorder, Contract Research Services, PhysioMimix OOC, Drug-induced liver injury, ADME, disease modeling, 3D cell culture, Aminal alternative, New Alternative approaches, COVID 19, Drug absorption, Drug metabolism, Bioavailability, Respiratory infection, DILI
Total Rounds
5
Last Round
Wed Jun 30 2021
Last Round Series
Series B
Last Round Raised
$ 12,000,000
